Partin AW - Search Results

1

Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer.

Partin AW, Steinberg GD, Pitcock RV, Wu L, Piantadosi S, Coffey DS, Epstein JI. Partin AW, et al. Cancer. 1992 Jul 1;70(1):161-8. doi: 10.1002/1097-0142(19920701)70:1<161::aid-cncr2820700126>3.0.co;2-5. Cancer. 1992. PMID: 1606538

2

Comparison of nuclear shape in aspirated and histologic specimens of prostatic carcinoma.

Tardif CP, Partin AW, Qaqish B, Epstein JP, Mohler JL. Tardif CP, et al. Among authors: partin aw. Anal Quant Cytol Histol. 1992 Dec;14(6):474-82. Anal Quant Cytol Histol. 1992. PMID: 1292446

3

The use of nuclear morphometry to predict response to therapy in Wilms' tumor.

Gearhart JP, Partin AW, Leventhal B, Beckwith JB, Epstein JI. Gearhart JP, et al. Among authors: partin aw. Cancer. 1992 Feb 1;69(3):804-8. doi: 10.1002/1097-0142(19920201)69:3<804::aid-cncr2820690332>3.0.co;2-7. Cancer. 1992. PMID: 1309682

4

Cell motility as an index of metastatic ability in prostate cancers: results with an animal model and with human cancer cells.

Partin AW, Mohler JL, Coffey DS. Partin AW, et al. Cancer Treat Res. 1992;59:121-30. doi: 10.1007/978-1-4615-3502-7_11. Cancer Treat Res. 1992. PMID: 1347689 No abstract available.

5

The biology of prostate cancer: new and future directions in predicting tumor behavior.

Partin AW, Carter HB, Epstein JI, Coffey DS. Partin AW, et al. Monogr Pathol. 1992;(34):198-218. Monogr Pathol. 1992. PMID: 1406742 Review.

6

A quantitative histological analysis of the dilated ureter of childhood.

Lee BR, Partin AW, Epstein JI, Quinlan DM, Gosling JA, Gearhart JP. Lee BR, et al. Among authors: partin aw. J Urol. 1992 Nov;148(5):1482-6. doi: 10.1016/s0022-5347(17)36944-6. J Urol. 1992. PMID: 1433552 Free article.

7

Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy.

Epstein JI, Pizov G, Steinberg GD, Carter HB, Pitcock R, Armas OA, Partin A, Walsh PC. Epstein JI, et al. J Urol. 1992 Jul;148(1):87-91. doi: 10.1016/s0022-5347(17)36518-7. J Urol. 1992. PMID: 1613888 Free article. Review.

8

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.

Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC. Partin AW, et al. J Urol. 1990 Apr;143(4):747-52. doi: 10.1016/s0022-5347(17)40079-6. J Urol. 1990. PMID: 1690309 Free article.

9

The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.

Carter HB, Partin AW, Epstein JI, Chan DW, Walsh PC. Carter HB, et al. Among authors: partin aw. J Urol. 1990 Nov;144(5):1167-70; discussion 1170-1. doi: 10.1016/s0022-5347(17)39683-0. J Urol. 1990. PMID: 1700143

10

Influence of age and endocrine factors on the volume of benign prostatic hyperplasia.

Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC. Partin AW, et al. J Urol. 1991 Feb;145(2):405-9. doi: 10.1016/s0022-5347(17)38353-2. J Urol. 1991. PMID: 1703242 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

614 results

Search Page

Filters